Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 45

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 45
---
;    |

| ● | success of our competitors                 
 in developing or commercializing products; |

| ● | ability to commercialize or                                                                                  
 obtain regulatory approvals for our product, or delays in commercializing or obtaining regulatory approvals; |

| ● | strategic transactions undertaken 
 by us;                            |

| ● | additions or departures of 
 key personnel;             |

| ● | prevailing economic conditions; |

| ● | disputes concerning our intellectual  
 property or other proprietary rights; |

| ● | FDA or other U.S. or foreign                                    
 regulatory actions affecting us or the pharmaceutical industry; |

| ● | sales of our common stock by                         
 our officers, directors or significant stockholders; |

<div align='center'>22</div>

| ● | future sales or issuances of     
 equity or debt securities by us; |

| ● | business disruptions caused                       
 by earthquakes, fires or other natural disasters; |

| ● | the exercise and sale of any                                                                     
 outstanding warrants or options, including the exercise of the Warrants issued in this offering; |

| ● | changes in our Board or management; |

| ● | issuance of new or changed                                    
 securities analysts’ reports or recommendations regarding us; |

| ● | any future COVID-19 outbreaks; |

| ● | changes in our capital structure,                      
 such as future issuances of debt or equity securities; |

| ● | short sales, hedging and other                           
 derivative transactions involving our capital stock; and |

| ● | general economic and geopolitical 
 conditions.                       |

In addition, if the market for stocks in our industry
or the stock market, in general, experiences a loss of investor confidence, the trading price of our common stock could decline for reasons
unrelated to our business, results of operations or financial condition. The trading price of our common stock might also decline in reaction
to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of
volatility in the market price of a company’s securities, securities class action litigation has often been brought against that
company. If our stock price is volatile, we may become the target of securities litigation. Securities litigation could result in substantial
costs and divert our management’s attention and resources from our business. This could have a material adverse effect on our business,
results of operations, and financial condition.

We may not be able to maintain the listing of our common stock on Nasdaq, which could adversely affect our liquidity and the trading volume and market price of our common